Back to 
Loring Wolcott & Coolidge Fiduciary Advisors LLP
Loring Wolcott & Coolidge Fiduciary Advisors LLP
LGNDShowing 0 of 2 quarters
Position history for Loring Wolcott & Coolidge Fiduciary Advisors LLP's holdings in Ligand Pharmaceuticals Incorporated
No. Loring Wolcott & Coolidge Fiduciary Advisors exited its LGND (Ligand Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 16 shares worth $2,000. Loring Wolcott & Coolidge Fiduciary Advisors first reported LGND in Q2 2019 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.